You are here:

Tenofovir disoproxil fumarate (Viread®)

Advice

Tenofovir disoproxil fumarate is recommended in combination with other antiretroviral agents in HIV infected patients over 18 years of age experiencing virological failure.

REASONS FOR ADVICE.

Tenofovir produces a clinically relevant viral response in heavily pre-treated patients experiencing early virological failure. Tenofovir should be initiated under the general supervision of specialists experienced in the management of HIV/AIDs patients.

Drug Details

Drug Name: Tenofovir disoproxil fumarate (Viread®)
SMC Drug ID: 03/02
Manufacturer: Gilead Sciences Ltd
Indication: HIV
BNF Category:
Sub Category: 5.3 Antiviral Drugs
Submission Type: Full submission
Status: Restricted
Date Advice Published: 14 June 2002

Back